L1

These detailed notes cover the foundations of pharmacology, its history, drug development, and core scientific concepts as presented in the lecture transcript and accompanying slides.

I. Definitions and Scope of Pharmacology

  • Pharmacology is defined as the science of drugs, encompassing their origin, composition, pharmacokinetics, therapeutic use, and toxicology.

  • The term is derived from the Greek word pharmakon, which reflects the duality of substances as both a "remedy" and a "poison".

  • Drugs vs. Medicines:

    • A drug is any man-made, natural, or endogenous molecule that exerts a biochemical or physiological effect on a cell, tissue, or organism.

    • A medicine is a drug specifically aimed at preventing, alleviating, or curing a symptom or disease, meaning it must have a beneficial effect.

    • While all medicines are drugs, not all drugs are medicines (e.g., illicit drugs like heroin or poisons).

  • Allopathic Medicine: Pharmacology is a core component of allopathic medicine—conventional Western medicine—which is evidence-based and focuses on treating symptoms and pathology with interventions that are the opposite of the disease process (the opposite of homeopathy).

  • Interdisciplinary Nature: Pharmacology links chemistry, physiology, and pathology, working closely with fields like neuroscience, immunology, and cancer biology.

II. Historical Evolution of Pharmacology

  • Ancient Origins:

    • 16th Century BC: The Ebers papyrus contains an extensive list of pharmacological compounds known to ancient Egyptians.

    • 6th Century BC: The Sushruta Samhita is one of the earliest Indian Ayurvedic documentations of medical substances.

    • 1st Century BC: The Shennong Ben Cao Jing (China) described thousands of prescriptions, while Dioscorides' De Materia Medica became the most influential Western work on the subject.

  • Scientific Beginnings (17th–19th Century):

    • The mid-19th century saw an explosion in biomedical interest, with the founding of the first Pharmacology Department by Rudolf Buchheim in Germany (1847).

    • Major pharmaceutical companies like Merck, Pfizer, and Bayer had their origins in the mid-to-late 19th century.

  • The Modern Era (20th Century):

    • 1920s: Banting and Best isolated insulin for diabetes treatment.

    • 1928: Alexander Fleming discovered penicillin, revolutionising the treatment of bacterial infections.

    • 1940s–50s: The first randomised controlled trial was conducted (streptomycin for TB), and the NIH established the Laboratory of Chemical Pharmacology to study drug metabolism.

III. Natural Sources of Drugs: Case Studies

Plants have historically been a primary source of bioactive compounds used for defense against pests that humans adapted for therapy.

  1. Willow Tree (Salicylates): Ancient Romans used willow bark for pain. Pure salicin was isolated in 1828, and Bayer began the industrial synthesis of Aspirin in 1897.

  2. Belladonna (Atropine): Derived from deadly nightshade, it inhibits the parasympathetic nervous system. It was historically used to dilate pupils for aesthetic reasons.

  3. Sweet Wormwood (Artemisinin): Long used in traditional Chinese medicine to treat fever, it was isolated by Chinese military scientists in the 1970s and remains a highly effective anti-malarial (discovery led to a Nobel Prize for Tu Youyou).

IV. Drug Discovery and Development

  • Traditional vs. Modern: Discovery has shifted from serendipitous trial and error to rational drug design and target identification.

  • The Pipeline:

    • Pre-clinical research: Testing in animal models and cells to ensure safety and efficacy.

    • Clinical trials: Occur in three phases (Phase I, II, and III).

    • Regulatory approval: In Australia, the Therapeutic Goods Administration (TGA) regulates all products making therapeutic claims; in the US, it is the FDA.

  • Timeline and Cost: It can take 30 years from discovery to market. The process is extremely expensive, though Artificial Intelligence (AI) is now being used to speed up the discovery phase by finding connections humans might miss.

V. Core Pharmacological Concepts

  • Pharmacodynamics (PD): What the drug does to the body (targets, potency, efficacy, selectivity).

  • Pharmacokinetics (PK): What the body does to the drug, often described by the acronym ADME:

    1. Absorption: How the drug enters the body (formulation, mode of delivery).

    2. Distribution: Where the drug goes, including whether it crosses the blood-brain barrier (BBB) or stays in fat stores.

    3. Metabolism: How the body breaks down the drug, often through first-pass metabolism in the liver.

    4. Excretion: How the drug leaves (clearance and half-life).

  • Classic Drug Targets:

    • Receptors: e.g., Ranitidine (histamine receptor antagonist).

    • Ion Channels: e.g., Nifedipine (calcium channel blocker).

    • Enzymes: e.g., Statins (cholesterol) or Aspirin.

    • Transporters/Carrier Molecules: e.g., Fluoxetine (serotonin transporter inhibitor).

  • Therapeutic Index (TI): The ratio between a toxic dose (TD50) and an effective dose (ED50). A larger gap indicates a safer drug.

    • Paracelsus' Quote: "The dosage makes the thing not a poison".

    • Comparison: Vitamin D has a very high TI (~200,000), whereas paracetamol has a low TI (10–20), meaning 20 pills can be fatal.

VI. Drug Nomenclature

A marketed drug generally has three names:

  1. Chemical Name: The precise IUPAC name describing the structure (e.g., N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine).

  2. Generic Name: The simplified name used in courses; the suffix often identifies the drug class (e.g., "-statin" for cholesterol).

  3. Brand Name: The catchy, proprietary name created by marketing divisions (e.g., Prozac for fluoxetine).

  • Naming Challenges: Different countries use different names for the same drug (e.g., paracetamol in Australia vs. acetaminophen in the USA), which historically delayed the discovery of side effects for drugs like thalidomide.